World's Best Scientists 2026 revealed!
Joseph H. Friedman

Joseph H. Friedman

D-Index & Metrics

Medicine

D-Index
94
Citations
36675
World Ranking
10398
National Ranking
5354

Overview

Joseph H. Friedman is affiliated with Brown University in the United States and has contributed extensively to the field of Medicine, with a particular focus on Neurology and Psychiatry and Mental Health. Their research portfolio includes over 100 publications, with significant work addressing neurological disorders, especially Parkinson's disease and related movement disorders.

The main fields of study covered in their work include:

  • Medicine

The subfields of study further specify areas such as:

  • Neurology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Epidemiology
  • Cognitive Neuroscience

Their research topics emphasize neurological conditions and treatments alongside psychiatric components, including:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Schizophrenia research and treatment
  • Genetic Neurodegenerative Diseases
  • Neurological and metabolic disorders
  • Autism Spectrum Disorder Research
  • Botulinum Toxin and Related Neurological Disorders

Joseph H. Friedman has published in several journals, with frequent contributions to:

  • Parkinsonism & Related Disorders
  • Clinical Neuropharmacology
  • Movement Disorders Clinical Practice
  • Clinical Parkinsonism & Related Disorders
  • Parkinson s Disease

Key co-authors who have frequently collaborated with Friedman include:

  • Umer Akbar
  • Robert A. Hauser
  • Duk Soo Kim
  • Stanley N. Caroff
  • William G. Ondo

Recent notable publications include:

  • "Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression", 2021, JAMA
  • "Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3", 2020, Science Translational Medicine
  • "Movement disorders induced by psychiatric drugs that do not block dopamine receptors", 2020, Parkinsonism & Related Disorders
  • "Recovery incentives program: California's contingency management benefit", 2023, Preventive Medicine
  • "Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies", 2022, Parkinsonism & Related Disorders

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

    W. Koller;C. W. Olanow;R. Rodnitzky;J. S. Fink

  • Validity and reliability of a rating scale for the primary torsion dystonias

    R. E. Burke;S. Fahn;C. D. Marsden;S. B. Bressman

  • Effect of deprenyl on the progression of disability in early Parkinson's disease

    I. Shoulson;S. Fahn;D. Oakes;C. Odoroff

  • Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease.

    A Rozanski;C N Bairey;D S Krantz;J Friedman

  • Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group

    Bernard Ravina;Karen Marder;Hubert H. Fernandez;Joseph H. Friedman

  • Fatigue in Parkinson's disease: a review.

    Joseph H. Friedman;Richard G. Brown;Cynthia Comella;Carol E. Garber

  • Speech production, syntax comprehension, and cognitive deficits in Parkinson's disease.

    Philip Lieberman;Edward Kako;Edward Kako;Joseph Friedman;Joseph Friedman;Gary Tajchman;Gary Tajchman

  • Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease

    Shannon Km;Bennett Jp;Friedman Jh

  • A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit

    M Flint Beal;David Oakes;Ira Shoulson

  • Fatigue in Parkinson's disease

    J. Friedman;H. Friedman

  • Orienting of visual attention in progressive supranuclear palsy.

    Robert D. Rafal;Michael I. Posner;Joseph H. Friedman;Albrecht W. Inhoff

  • Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.

    Herbert Y Meltzer;Roger Mills;Stephen Revell;Hilde Williams

  • Effects of fatigue on physical activity and function in patients with Parkinson's disease.

    Carol Ewing Garber;Joseph H. Friedman

  • Fatigue Rating Scales Critique and Recommendations by the Movement Disorders Society Task Force on Rating Scales for Parkinson's Disease

    Joseph H. Friedman;Joseph H. Friedman;Guido Alves;Peter Hagell;Johan Marinus

  • Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

    Joseph H. Friedman;Stewart A. Factor

  • Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study

    R. N. Alcalay;E. Caccappolo;H. Mejia-Santana;M. X. Tang

  • A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

    M. F. Brin;K. E. Lyons;J. Doucette;C. H. Adler

  • Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

    Tatiana Foroud;S. K. Uniacke;L. Liu;Nathan D Pankratz

  • Neuropsychiatric symptoms in Parkinson's disease

    Joseph Friedman

Frequent Co-Authors

Hubert H. Fernandez
Hubert H. Fernandez Cleveland Clinic
Laura Marsh
Laura Marsh Baylor College of Medicine
Danna Jennings
Danna Jennings Denali Therapeutics (United States)
Karen Marder
Karen Marder Columbia University
Stanley Fahn
Stanley Fahn Columbia University
Martha Nance
Martha Nance Park Nicollet Health Services
William K. Scott
William K. Scott University of Miami
Elan D. Louis
Elan D. Louis The University of Texas Southwestern Medical Center
Janet Grace
Janet Grace Brown University
Steven J. Frucht
Steven J. Frucht New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a wide range of online healthcare degrees and career options tailored for different backgrounds and goals. Whether you’re just starting out or looking to specialize, there are educational pathways that fit your schedule and needs.

For nurses aiming to advance quickly, short dnp programs help you earn a Doctor of Nursing Practice in less time. Those seeking affordability can consider options highlighted as the cheapest dnp program, ensuring high-quality education without a hefty price tag.

Entry-level opportunities are also available, such as accredited online lpn programs for those seeking a faster route to patient care roles. For Registered Nurses interested in mental health, bsn to np programs online provide flexible, streamlined options to become a psychiatric mental health nurse practitioner.

These online pathways offer the convenience of remote learning and the flexibility to balance work or personal commitments—making them excellent choices as you plan your future in healthcare.

Best Scientists Citing Joseph H. Friedman

Trending Scientists

Recently Published Articles